# FDA recall D-1328-2014

> **Pfizer Us Pharmaceutical Group** · Class I · drug recall initiated 2014-03-06.

## Product

Effexor XR (venlafaxine HCl) Extended-Release Capsules, 150 mg, packaged in a) 30-count Unit of Use bottles (NDC 0008-0836-21) UPC 3 0008-0836-21 7; b) 90-count Unit of Use bottles (NDC 0008-0836-22) UPC 3 0008-0836-22 4; Rx only, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA 19101.

## Reason for recall

Presence of Foreign Tablets/Capsules: A Pharmacist reported that a bottle of Effexor XR 150 mg capsules contained a single peach colored capsule printed TKN250 which was identified as a Tikosyn (dofetilide) capsule.

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-1328-2014
- **Recalling firm:** Pfizer Us Pharmaceutical Group
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-03-06
- **Report date:** 2014-05-28
- **Termination date:** 2017-05-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1328-2014

## Citation

> AI Analytics. FDA recall D-1328-2014. Retrieved 2026-06-16 from https://api.ai-analytics.org/recall/D-1328-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*